SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination (Q111911054)

1

0 references

Asha Patnaik

2

0 references

Joann Salvemini

3

0 references

Sanjeev Jain

4

0 references

Katherine Lee

5

0 references

Daniel Lozeau

6

0 references

Qingping Yao

The Ubiquitin Code of NODs Signaling Pathways in Health and Disease

7

0 references

language of work or name

English

0 references

publication date

2 May 2022

0 references

published in

Clinical Immunology

0 references

volume

238

0 references

page(s)

109027

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Mapping the human genetic architecture of COVID-19

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Expansion of Phenotypic and Genotypic Spectrum in Yao Syndrome: A Case Series

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Activation of innate immune antiviral responses by Nod2

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Immune diseases caused by mutations in kinases and components of the ubiquitin system

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Ubiquitination in disease pathogenesis and treatment

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

NOD2-associated autoinflammatory disease: a large cohort study

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

A new category of autoinflammatory disease associated with NOD2 gene mutations

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Viral evasion and subversion of pattern-recognition receptor signalling

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2.

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

NOD1 and NOD2: Beyond Peptidoglycan Sensing.

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Trained immunity: a memory for innate host defense

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Case of NOD2-Associated Autoinflammatory Disease Successfully Treated With Sulfasalazine.

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Using Ubiquitin Binders to Decipher the Ubiquitin Code

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

The unravelling of the ubiquitin system

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Regulation of Cell Death and Immunity by XIAP

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Adult-onset Still's disease following mRNA COVID-19 vaccination

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Adult-onset Still's disease following COVID-19 vaccination

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico‐histopathologic presentation

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Ubiquitination of ATF6 by disease-associated RNF186 promotes the innate receptor-induced unfolded protein response

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Guillain‐Barre syndrome following COVID‐19 vaccines: A scoping review

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027

Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines

9 May 2022

1 reference

https://api.crossref.org/works/10.1016/j.clim.2022.109027